Aze Wilson
13PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Jan 21, 2026
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort Study.Eryn Rooney, Gio R Dela Cruz, Terry Ponich
|Sep 17, 2025
IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel Disease.Navneet Natt, Monica Gindi, Gio R Dela Cruz
|May 08, 2024
Infliximab Tissue Concentrations in Patients With Stable Ulcerative Colitis Are Correlated With More Durable Infliximab-associated Disease Remission.John Choi, Qian Wang, Melanie Beaton
|Sep 16, 2022
Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A Genotype.Bethany Choi, Michael Sey, Terry Ponich
|Jul 27, 2021
A Comparative Analysis of Drug Therapy, Disease Phenotype, and Health Care Outcomes for Men and Women with Inflammatory Bowel Disease.Emily M Heath, Richard B Kim, Aze Wilson
|Mar 04, 2021
High quantities: Evaluating the association between cannabis use and propofol anesthesia during endoscopy.Ngozi Imasogie, Rhiannon V Rose, Aze Wilson
Pageof 3
